SAVIMS

Reference Library

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Understanding the Pfizer-BioNTech COVID-19 Vaccine: What You Need to Know

Reference: U.S. Department of Health and Human Services. (2021). Fact sheet for recipients and caregivers: Emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 12 years of age and older. Retrieved from www.cvdvaccine.com Summary: The Pfizer-BioNTech COVID-19 Vaccine is offered under emergency use authorization (EUA) to prevent […]

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of the FLCCC COVID-19 Management Protocol

Reference: Marik, P. (2021). FLCCC Alliance – COVID-19 Management Protocol (06-21-2021). Retrieved from www.flccc.net Summary: The FLCCC Alliance’s COVID-19 Management Protocol provides a multifaceted approach to treating COVID-19, focusing on prevention and early intervention to mitigate severe disease outcomes. The protocol outlines three key treatment strategies: MATH+, I-MASK+, and I-RECOVER, tailored to different stages of

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety of mRNA Covid-19 Vaccines in Pregnant Persons Supplementary appendix

Reference: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C. K., Liu, R., Chang, K. T., Ellington, S. R., Burkel, V. K., Smoots, A. N., Green, C. J., Licata, C., Zhang, B. C., Alimchandani, M., Mba-Jonas, A., Martin, S. W., Gee, J. M.,

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety of mRNA Covid-19 Vaccines in Pregnant Persons

Reference: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., … & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine, 384(24), 2273-2282. https://doi.org/10.1056/NEJMoa2104983 Summary: The article evaluates the safety of mRNA Covid-19 vaccines in pregnant individuals, utilising

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Long Haul COVID-19 Syndrome: Management and Treatment Protocols

Reference: Front Line COVID-19 Critical Care Alliance. (2021). Prevention & treatment protocols for COVID-19: Management protocol for Long Haul COVID-19 Syndrome (LHCS). Retrieved from https://flccc.net/flccc-protocols-a-guide-to-the-management-of-covid-19 Summary: The Front Line COVID-19 Critical Care Alliance (FLCCC) has developed a consensus protocol for managing Long Haul COVID-19 Syndrome (LHCS), which presents a range of symptoms including fatigue, cognitive

Other scientific evidence, Resource Type, Treatment

Human Cells Can Rewrite RNA into DNA: A Groundbreaking Discovery

Reference: Rees, V. (2021, June 14). Human cells can write RNA sequences into DNA, study shows. Drug Target Review. https://www.drugtargetreview.com/news/92931/human-cells-can-write-rna-sequences-into-dna-study-shows/ Summary: Researchers at Thomas Jefferson University have discovered that human polymerase theta can convert RNA segments back into DNA, challenging the traditional understanding of molecular biology. This finding suggests that RNA messages may serve as

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Efficacy and Safety of Single-Dose Ad26.COV2.S Covid-19 Vaccine

Reference: Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., Neuzil, K. M., Corey, L., Cauwenberghs, N., Tanner, T., Hardt,

COVID-19, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Viral illnesses

Improved Diagnosis of SARS-CoV-2 Using Nucleoprotein and Spike Protein Fragment in ELISA Tests

Reference: De Marco Verissimo, C., O’Brien, C., López Corrales, J., Dorey, A., Cwiklinski, K., Lalor, R., … & Doyle, S. (2021). Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. Epidemiology and Infection, 149, e140, 1–11. https://doi.org/10.1017/S0950268821001308 Summary: The article discusses advancements in diagnosing SARS-CoV-2 through the

Ethics, Other scientific evidence, Reference Library, Resource Type

The Heartbreaking Reality of South Africa’s Healthcare System

Reference: De Maayer, T. (2022). How do you manage to come to work every day, fail at your job of ensuring basic healthcare for the people you serve and still sleep at night? DM168. Summary: In a poignant open letter, Dr Tim De Maayer, a paediatrician at Rahima Moosa Mother and Child Hospital, sheds light

COVID-19, Ivermectin, Treatment, Viral illnesses

The Mechanisms of Action of Ivermectin Against SARS-CoV-2

Reference: Kamber Zaidi, A., & Dehgani-Mobaraki, P. (2021). The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. The Journal of Antibiotics, 74(7), 441-454. https://doi.org/10.1038/s41429-021-00430-5 Summary: This review article examines the potential of Ivermectin as a therapeutic agent against SARS-CoV-2 amidst the COVID-19 pandemic. It highlights Ivermectin’s mechanism of action, including its

Scroll to Top